• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿苯达唑联合西咪替丁治疗人体囊型包虫病的初步观察

Initial observation on albendazole in combination with cimetidine for the treatment of human cystic echinococcosis.

作者信息

Wen H, Zhang H W, Muhmut M, Zou P F, New R R, Craig P S

机构信息

Department of Surgery and Pharmaceutics, Xinjiang Medical College, China.

出版信息

Ann Trop Med Parasitol. 1994 Feb;88(1):49-52. doi: 10.1080/00034983.1994.11812834.

DOI:10.1080/00034983.1994.11812834
PMID:8192515
Abstract

Concentrations of albendazole were measured, by high-pressure liquid chromatography, in 19 patients being treated for cystic echinococcosis. All of the patients were given three 4-week courses of albendazole (20 mg/kg/day), separated by 10-day-long drug-free intervals. Seven patients also received three courses of cimetidine (10 mg/kg/day). Concentrations of albendazole sulphoxide (ABZSX) were significantly higher in samples of bile and hydatid cyst fluid from the patients receiving albendazole and cimetidine than in those from patients receiving albendazole alone (P < 0.05). The therapeutic benefit of the combined drug treatment, which was well-tolerated, was more than that with albendazole alone.

摘要

采用高压液相色谱法测定了19例接受阿苯达唑治疗的囊性棘球蚴病患者体内阿苯达唑的浓度。所有患者均接受三个为期4周的阿苯达唑疗程(20 mg/kg/天),疗程之间间隔10天无药期。7例患者还接受了三个疗程的西咪替丁(10 mg/kg/天)治疗。接受阿苯达唑和西咪替丁联合治疗的患者,其胆汁和棘球蚴囊液样本中阿苯达唑亚砜(ABZSX)的浓度显著高于仅接受阿苯达唑治疗的患者(P < 0.05)。联合药物治疗耐受性良好,其治疗效果优于单独使用阿苯达唑。

相似文献

1
Initial observation on albendazole in combination with cimetidine for the treatment of human cystic echinococcosis.阿苯达唑联合西咪替丁治疗人体囊型包虫病的初步观察
Ann Trop Med Parasitol. 1994 Feb;88(1):49-52. doi: 10.1080/00034983.1994.11812834.
2
Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data.人囊型包虫病中阿苯达唑亚砜的囊内浓度:一项对个体患者数据的系统评价与分析
Parasitol Res. 2016 Aug;115(8):2995-3001. doi: 10.1007/s00436-016-5054-x. Epub 2016 Apr 16.
3
Penetration of albendazole sulphoxide into hydatid cysts.阿苯达唑亚砜在包虫囊肿中的渗透情况。
Gut. 1987 Jan;28(1):75-80. doi: 10.1136/gut.28.1.75.
4
Effect of dose increase or cimetidine co-administration on albendazole bioavailability.剂量增加或与西咪替丁联合使用对阿苯达唑生物利用度的影响。
Am J Trop Med Hyg. 2000 Nov-Dec;63(5-6):270-3.
5
Pharmacology and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine.
Parasitology. 1996 Aug;113 ( Pt 2):111-21. doi: 10.1017/s003118200006635x.
6
A pharmacology-based comparison of the activity of albendazole and flubendazole against Echinococcus granulosus metacestode in sheep.基于药理学的阿苯达唑和氟苯达唑对绵羊细粒棘球蚴原头蚴活性的比较。
Acta Trop. 2013 Sep;127(3):216-25. doi: 10.1016/j.actatropica.2013.05.004. Epub 2013 May 18.
7
The effect of combination therapy with albendazole and praziquantel on hydatid cyst treatment.阿苯达唑和吡喹酮联合治疗对包虫囊肿的疗效。
Parasitol Res. 2008 Jun;103(1):195-9. doi: 10.1007/s00436-008-0954-z.
8
Pharmacokinetics of albendazole in man.阿苯达唑在人体中的药代动力学。
Eur J Clin Pharmacol. 1986;30(6):705-8. doi: 10.1007/BF00608219.
9
Preoperative albendazole and scolices viability in patients with hepatic echinococcosis.肝包虫病患者术前使用阿苯达唑与头节活力
World J Surg. 2005 Jun;29(6):750-3. doi: 10.1007/s00268-005-7691-6.
10
[Variation of albendazole sulfoxide concentrations in serum, hydatid cyst membrane and liquid as a function of time. Liquid phase chromatographic study].[阿苯达唑亚砜在血清、包虫囊肿膜及囊液中的浓度随时间的变化。液相色谱研究]
Ann Pharm Fr. 1987;45(6):439-44.

引用本文的文献

1
Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data.人囊型包虫病中阿苯达唑亚砜的囊内浓度:一项对个体患者数据的系统评价与分析
Parasitol Res. 2016 Aug;115(8):2995-3001. doi: 10.1007/s00436-016-5054-x. Epub 2016 Apr 16.
2
A review of pharmacokinetic drug-drug interactions with the anthelmintic medications albendazole and mebendazole.抗蠕虫药物阿苯达唑和甲苯达唑的药代动力学药物相互作用综述。
Clin Pharmacokinet. 2015 Apr;54(4):371-83. doi: 10.1007/s40262-015-0243-9.
3
Present-day anthelmintics and perspectives on future new targets.
当代驱虫药及未来新靶标的研究进展。
Parasitol Res. 2014 Jul;113(7):2425-33. doi: 10.1007/s00436-014-3969-7. Epub 2014 Jun 4.
4
Drug treatment of tropical parasitic infections: recent achievements and developments.热带寄生虫感染的药物治疗:近期成果与进展
Drugs. 2000 Nov;60(5):985-95. doi: 10.2165/00003495-200060050-00002.
5
Anthelmintics. A comparative review of their clinical pharmacology.驱虫药。其临床药理学的比较综述。
Drugs. 1997 May;53(5):769-88. doi: 10.2165/00003495-199753050-00004.
6
Clinical pharmacokinetics in the treatment of tropical diseases. Some applications and limitations.热带病治疗中的临床药代动力学。一些应用与局限。
Clin Pharmacokinet. 1994 Aug;27(2):150-65. doi: 10.2165/00003088-199427020-00006.